María Martínez-García

10PUBLICATIONS
70CO-AUTHORS
ChemotherapyCancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markersSolid tumoursTumour immunology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (10)

|Apr 20, 2026
Cibisatamab and FAP-4-1BBL in microsatellite-stable colorectal cancer: a phase 1b trial.

|Oct 10, 2024
Salvage reirradiation for recurrent glioblastoma: a retrospective case series analysis.

Anna Lucas Calduch, Miquel Macià Garau, Salvador Villà Freixa

|May 10, 2023
A first-in-human study of the fibroblast activation protein-targeted, 4-1BB agonist RO7122290 in patients with advanced solid tumors.

Ignacio Melero, Tamara Tanos, Mariana Bustamante

|Mar 29, 2023
Gal-1 Expression Analysis in the GLIOCAT Multicenter Study: Role as a Prognostic Factor and an Immune-Suppressive Biomarker.

Neus Martínez-Bosch, Noelia Vilariño, Francesc Alameda

|Mar 08, 2022
SEOM-GEINO clinical guideline of systemic therapy and management of brain central nervous system metastases (2021).

María Martínez-García, Sonia Servitja Tormo, Noelia Vilariño Quintela

|Oct 27, 2020
RNA sequencing and Immunohistochemistry Reveal ZFN7 as a Stronger Marker of Survival than Molecular Subtypes in G-CIMP-negative Glioblastoma.

Anna Esteve-Codina, Francesc Alameda, Cristina Carrato

Pageof 2

Frequent Collaborators

3 joint publications

Estela Pineda

3 joint publications

Anna Esteve-Codina

3 joint publications

Anna Esteve Gómez

2 joint publications

Oscar Gallego